Palatin Technologies, Inc. PTN

Q4 FY2026 · ended Jun 30, 2026 · Revenue $300,770 · Filed Sep 28, 2026

Palatin Technologies, Inc. (PTN) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $300,770 and a net loss of $4.4 million. Free cash flow was -$2.7 million. As of Jun 30, 2026 it held $7.5 million in cash and investments and $223,679 in total debt.

Revenue
$300,770
Net income
$-4.36M
-95.5% vs year-ago quarter
Operating cash flow
$-2.69M
+34.2% vs year-ago quarter
Free cash flow
$-2.69M
+34.2% vs year-ago quarter
EPS
$-1.11
+59.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
1.78M
+83.0% vs year-ago quarter
Net cash
$7.27M
Q4 FY2026
Operating margin
-1469.5%
Q4 FY2026

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTN (Nasdaq)
Fiscal year ends
June 30
Incorporated in
NJ
Headquarters
Cranbury, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
911216
Former names
INTERFILM INC (until Jun 14, 1996)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q4 FY2026
Jun 30, 2026
Q3 FY2026
Mar 31, 2026
Q2 FY2026
Dec 31, 2025
Q1 FY2026
Sep 30, 2025
Q4 FY2025
Jun 30, 2025
Revenue
$300,770
$3.9M
$116,036
$8.8M
$0
Operating income
-$4.4M
-$1.6M
-$7.3M
$4.7M
-$2.3M
Net income
-$4.4M
-$1.4M
-$7.3M
$4.7M
-$2.2M
Diluted EPS
-$1.11
-$0.37
-$2.86
$4.26
-$2.72
Operating cash flow
-$2.7M
-$4.4M
-$4.8M
-$1.6M
-$4.1M
Free cash flow
-$2.7M
-$4.5M
-$4.8M
—
-$4.1M
Total assets
$8.5M
$13.2M
$17.9M
$8.6M
$3.3M
Total liabilities
$1.8M
$2.6M
$6.5M
$8.2M
$8.0M
Stockholders' equity
$6.7M
$10.6M
$11.5M
$396,399
-$4.8M
Cash and investments
$7.5M
$10.2M
$14.5M
$1.3M
$2.6M
Total debt
$223,679
$286,662
$348,788
$132,446
$163,781

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-K Annual report Sep 28, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Aug 3, 2026 Jul 28, 2026
8-K Current report
Listing notice, Regulation FD disclosure
May 18, 2026 May 18, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
8-K/A Amended current report
Shareholder vote results
Dec 19, 2025 Jul 25, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.